Breast cancer is becoming increasingly treatable, but in some cases the disease can resurface even decades after a patient ...

For biologists, seeing is believing. But sometimes biologists have a hard time seeing. One particularly vexing challenge is ...

To prevent the third most lethal cancer in Spain from becoming the second by 2030, clinicians are seeking to increase the ...

The AERIAL trial will assess LEU011, which has MHRA Innovation Passport status, for solid tumors, a challenging area compared ...

Fifty years since its discovery, scientists have finally worked out how a molecular machine found in mitochondria, the 'powerhouses' of our cells, allows us to make the fuel we need from sugars, a ...

Boca Raton, Florida, US, April 16, 2025 (GLOBE NEWSWIRE) -- INmune Bio Inc. (NASDAQ: INMB), a clinical-stage biotechnology company targeting inflammation and immunology through the innate immune ...

Pancreatic cancer is one of the most aggressive cancers and has one of the lowest survival rates-only 10% after five years.

Gastrointestinal Stromal Tumor Market to Grow Rapidly During the Study Period (2020–2034) Owing to the Launch of Emerging Therapies | DelveInsight According to DelveInsight’s analysis, the market for ...

Pancreatic cancer is one of the most aggressive cancers and has one of the lowest survival rates—only 10% after five years.

Cancer treatments can instigate ocular surface disease and other deleterious ocular side effects that optometrists can oversee and manage.

Chemokines, our body's chemical messengers, play a crucial role in regulating the immune response.  They are secreted by ...